|
LRSAM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.904900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.847910E-02 |
| Normal-vs-Stage2 |
7.200200E-01 |
| Normal-vs-Stage3 |
4.325700E-02 |
| Normal-vs-Stage4 |
1.540070E-02 |
| Stage1-vs-Stage2 |
3.888000E-01 |
| Stage1-vs-Stage3 |
8.313800E-01 |
| Stage1-vs-Stage4 |
2.120800E-01 |
| Stage2-vs-Stage3 |
3.255600E-01 |
| Stage2-vs-Stage4 |
1.353850E-01 |
| Stage3-vs-Stage4 |
3.579400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.175710E-02 |
| Normal-vs-AfricanAmerican |
7.579800E-01 |
| Normal-vs-Asian |
3.870400E-01 |
| Caucasian-vs-AfricanAmerican |
4.312000E-01 |
| Caucasian-vs-Asian |
4.789200E-01 |
| AfricanAmerican-vs-Asian |
8.280600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.702200E-01 |
| Normal-vs-Female |
5.224400E-03 |
| Male-vs-Female |
3.550000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.686330E-02 |
| Normal-vs-Age(41-60Yrs) |
8.403600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.102830E-01 |
| Normal-vs-Age(81-100Yrs) |
1.210640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.798200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.029800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.826000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.909400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.033000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.125000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.038760E-03 |
| Classical-VS-Follicular |
2.840400E-01 |
| Classical-VS-Other |
7.138200E-01 |
| Classical-VS-Normal |
1.113950E-02 |
| Tall-VS-Follicular |
7.592000E-04 |
| Tall-VS-Other |
2.240600E-01 |
| Tall-VS-Normal |
7.15520000027503E-07 |
| Follicular-VS-Other |
5.303000E-01 |
| Follicular-VS-Normal |
4.209200E-01 |
| Other-VS-Normal |
9.204400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.473800E-01 |
| Normal-vs-N1 |
1.782140E-02 |
| N0-vs-N1 |
2.904100E-02 |
|
|
